Tiantan Biological's first-half net profit falls 52.75% year on year; plans dividend of 1 yuan per 10 shares

证券时报··CN·Read original
3▲0 ▼1Impact / 5
Summary · why it matters

Tiantan Biological disclosed its semi-annual report on August 28. In the first half of 2026, it achieved operating revenue of 2.595 billion yuan, down 16.56% year on year. Net profit attributable to shareholders of the listed company was 299 million yuan, down 52.75% year on year. Basic earnings per share were 0.15 yuan. The company plans to distribute a cash dividend of 1 yuan per 10 shares, tax included. During the reporting period, lower selling prices led to a decline in operating revenue.

Impact on assets 1

Others▼ · 1 stocks
© 2026 MarketIVNews